Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Von: The International Multiple Sclerosis Genetics Consortium (IMSGC) and the Wellcome Trust Case Control Consortium 2 (WTCCC2), erschienen in „Nature“ (Vol. 476, Nr. 7359, August 2011)